Matsayin Pharmaceutical 1009119-65-6 Daclatasvir Don Maganin Hepatitis C Featured Image

Grade Pharmaceutical 1009119-65-6 Daclatasvir Don Maganin Hepatitis C

Takaitaccen Bayani:

Tsafta:≧99.0%

Matsayin inganci:Kamar yadda ake bukata

Takaddun shaida:COA, MOA, MSDS, da dai sauransu.

Iyawa:50Kgs kowace wata

Rayuwar Shelf:Shekaru Biyu

Aikace-aikace:mai hana furotin 5A mara tsari kuma ana amfani dashi don maganin cutar hanta

Amfanin Ƙungiya:Ƙwararrun tallace-tallacen tallace-tallace na fitarwa tare da horarwar sana'a a masana'anta

Aika mana imel Zazzage azaman PDF

Cikakken Bayani

FAQ

Tags samfurin

Samfurasuna	Daclatasvir2 HCl
Makamantu	N, N'-[[1,1'-Biphenyl] -4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1) -methylethyl) -2-oxo-2,1-ethanediyl]]] biscarbamic acid dimethyl ester hydrochloride;Saukewa: BMS790052
CAS No.	1009119-65-6
Bayyanar	Fari zuwa kodadde rawaya foda
Tsarin kwayoyin halitta	C₄₀H₅₀N₈O₆.2 (HCl)
Nauyin Kwayoyin Halitta	811.81
Amfani	Matsayin Magunguna don manufar Bincike
Shiryawa	Kamar yadda kuka bukata
Adana	Ajiye a cikin matsi, kwantena masu jure haske a wuri mai sanyi

Daclatasvir2HCl Cas:1009119-65-6
Abubuwa	Daidaitawa	Sakamako
Halaye	Fari zuwa kodadde rawaya foda	Kodi-rawaya foda
Abun ciki na ruwa	≦1.0%	0.25%
Tsafta	≧99%	99.7%
Najasa ɗaya	≦0.1%	0.06%
Ragowa akan kunnawa	≦0.1%	Ya bi
Kammalawa	Ya dace da ƙayyadaddun cikin gida.

Bayanin Kamfanin

√ Cikakken ƙwarewar gudanarwa a masana'anta da ƙwararrun masu bin fasaha;
√ Quality ne ko da yaushe mu saman la'akari, M QC tsarin;
√ 11 shekaru gogaggen fitar da tallace-tallace tawagar;
√ R&D mai zaman kansa;
√ Biyu da aka sanya hannu na dogon lokaci na GMP;
√ wadataccen albarkatu na masana'antu marasa aiki da yawa don aikin da aka keɓance;
√ Ƙwararren aiki mai inganci tare da madaidaiciyar hanya.
imgsaf